Teva Pharmaceuticals sued Philadelphia-based Amicus Therapeutics Tuesday in Pennsylvania Eastern District Court over the drugmaker’s alleged refusal to provide access to product samples in accordance with the federal CREATES Act. The law, enacted in 2019, provides a timeline and mechanism for generic drugmakers to obtain samples of approved medications to support new generic drug applications. The suit, filed by Shook, Hardy & Bacon, accuses Amicus of withholding samples of its Galafold treatment for Fabry disease. Counsel have not yet appeared for the defendant. The case is 2:21-cv-03105, Teva Pharmaceuticals Development, Inc., v. Amicus Therapeutics U.S., Inc.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.